Influence of Severity of Illness on the Effects of Eritoran Tetrasodium (E5564), a TLR4 Antagonist, in Patients With Severe Sepsis

Critical Care - United Kingdom
doi 10.1186/cc8062
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy